346 related articles for article (PubMed ID: 17681241)
1. An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer.
Barney BM; MacDonald OK; Lee CM; Rankin J; Gaffney DK
Brachytherapy; 2007; 6(3):201-6. PubMed ID: 17681241
[TBL] [Abstract][Full Text] [Related]
2. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
[TBL] [Abstract][Full Text] [Related]
3. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
4. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
[TBL] [Abstract][Full Text] [Related]
5. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
[TBL] [Abstract][Full Text] [Related]
6. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
Chong I; Hoskin PJ
Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
[TBL] [Abstract][Full Text] [Related]
7. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
Aydogan B; Mundt AJ; Smith BD; Mell LK; Wang S; Sutton H; Roeske JC
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):266-73. PubMed ID: 16618581
[TBL] [Abstract][Full Text] [Related]
8. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.
Solhjem MC; Petersen IA; Haddock MG
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1379-84. PubMed ID: 16029796
[TBL] [Abstract][Full Text] [Related]
9. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
11. Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
Jereczek-Fossa BA; Badzio A; Jassem J
Radiother Oncol; 2004 Aug; 72(2):175-81. PubMed ID: 15297136
[TBL] [Abstract][Full Text] [Related]
12. A new method of anatomically conformal vaginal cuff HDR brachytherapy.
Miller DA; Richardson S; Grigsby PW
Gynecol Oncol; 2010 Mar; 116(3):413-8. PubMed ID: 19892389
[TBL] [Abstract][Full Text] [Related]
13. Postoperative vaginal vault brachytherapy for node-negative Stage II (occult) endometrial carcinoma.
Ng TY; Nicklin JL; Perrin LC; Cheuk R; Crandon AJ
Gynecol Oncol; 2001 May; 81(2):193-5. PubMed ID: 11330948
[TBL] [Abstract][Full Text] [Related]
14. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
15. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer.
Bahng AY; Dagan A; Bruner DW; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):667-73. PubMed ID: 21300451
[TBL] [Abstract][Full Text] [Related]
16. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
17. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors.
Rittenberg PV; Lotocki RJ; Heywood MS; Krepart GV
Gynecol Oncol; 2005 Sep; 98(3):434-8. PubMed ID: 16005498
[TBL] [Abstract][Full Text] [Related]
18. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
Lei X; Shan JL; Tang C; Zhao KW
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
[TBL] [Abstract][Full Text] [Related]
19. Conservative management of stage I endometrial carcinoma after surgical staging.
Straughn JM; Huh WK; Kelly FJ; Leath CA; Kleinberg MJ; Hyde J; Numnum TM; Zhang Y; Soong SJ; Austin JM; Partridge EE; Kilgore LC; Alvarez RD
Gynecol Oncol; 2002 Feb; 84(2):194-200. PubMed ID: 11812074
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women.
Macdonald OK; Sause WT; Lee RJ; Lee CM; Dodson MK; Zempolich K; Gaffney DK
Gynecol Oncol; 2006 Nov; 103(2):661-6. PubMed ID: 16797682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
